This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Archived - Xiaokeshuping Jiangtangning Jiaonang
- Starting date:
- May 16, 2007
- Posting date:
- May 16, 2007
- Type of communication:
- Foreign Product Alert (FPA)
- Subcategory:
- Drugs
- Source of recall:
- Health Canada
- Issue:
- Product Safety, Undeclared Substance
- Audience:
- General Public
- Identification number:
- RA-12000326
These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.
Source of alert
Hong Kong Department of Health
Product name
Xiaokeshuping Jiangtangning Jiaonang
Manufacturer / Place of origin
China
Product description
Xiaokeshuping Jiangtangning Jiaonang capsules are red-and-white in colour. The capsules are contained in a foil package within in a white-and-green box bearing Chinese lettering.
Reason for warning
The Hong Kong Department of Health (HKDH) found Xiaokeshuping Jiangtangning Jiaonang capsules to contain the undeclared pharmaceutical drugs phenformin, rosiglitazone, and glibenclamide, which may be used in diabetes to lower blood sugar. The HKDH conducted the analysis following receipt of a report that one woman in China had been hospitalized due to a serious hypoglycaemic attack (very low blood sugar) after using Xiaokeshuping Jiangtangning Jiaonang.
Phenformin was previously used for the treatment of diabetes, but was removed from the Canadian market in 1977 and banned in several countries, including Hong Kong, Singapore, Germany, France and the U.S.
Rosiglitazone and glibenclamide are used to lower blood glucose in the treatment of diabetes. These prescription drugs should only be used under the supervision of a healthcare professional
Phenformin, rosiglitazone, and glibenclamide may cause hypoglycemia (low blood sugar), particularly when combined with other blood glucose-lowering substances.
Possible side effects
Diabetic patients using other oral anti-diabetic medications in addition to Xiaokeshuping Jiangtangning Jiaonang could suffer serious side effects, including serious, life-threatening hypoglycemia.
Symptoms of hypoglycemia may include sweating, nausea, and trembling, which may lead to headaches and blurred vision. In severe cases, hypoglycemia may cause seizures and coma.
What you should do
Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.
Background
Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.
Report a health or safety concern
- Call toll-free at 1-866-234-2345.
- Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.
Media enquiries
Health Canada
613-957-2983
Public enquiries
613-957-2991
1-866-225-0709
Images
Select thumbnail to enlarge - opens in a new window
